What does CUSIP 405024100 represent in this 13F holders report?

CUSIP 405024100 is the security identifier for HAE - HAEMONETICS CORP - Common Stock used to aggregate holder disclosures.

How many institutions held HAE - HAEMONETICS CORP - Common Stock in Q1 2021?

288 institutional investors reported HAE - HAEMONETICS CORP - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

HAEMONETICS CORP - Common Stock (HAE)

CUSIP: 405024100

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 46,480,294
Total 13F shares: 49,961,531
Share change: -143,533
Total reported value: $5,549,106,460
Put/Call ratio: 55%
Price per share: $111.01
Number of holders: 288
Value change: -$22,300,347
Number of buys: 148
Number of sells: 138

Quarterly Holders Quick Answers

What is CUSIP 405024100?
CUSIP 405024100 identifies HAE - HAEMONETICS CORP - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 405024100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HAE - HAEMONETICS CORP - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital Research Global Investors	13F	Company	12%	5,637,735	$669,481,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	10%	4,852,282	$576,208,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	10%	4,700,591	$558,195,000	—	31 Dec 2020	13F
Neuberger Berman Group LLC	13F	Company	6.1%	2,833,049	$335,642,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	5.3%	2,483,654	$294,934,000	—	31 Dec 2020	13F
FRANKLIN RESOURCES INC	13F	Company	3.9%	1,796,091	$213,286,000	—	31 Dec 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	3.4%	1,576,194	$187,173,000	—	31 Dec 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.9%	1,364,333	$162,014,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	2.6%	1,221,253	$145,024,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	2.6%	1,216,040	$144,404,000	—	31 Dec 2020	13F
Capital World Investors	13F	Company	2.5%	1,182,600	$140,434,000	—	31 Dec 2020	13F
EATON VANCE MANAGEMENT	13F	Company	2.1%	957,055	$113,650,000	—	31 Dec 2020	13F
LONDON CO OF VIRGINIA	13F	Company	2%	940,216	$111,650,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	1.5%	694,746	$82,502,000	—	31 Dec 2020	13F
WADDELL & REED FINANCIAL INC	13F	Company	1.4%	668,443	$79,378,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.4%	659,418	$78,308,000	—	31 Dec 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.3%	608,032	$72,204,000	—	31 Dec 2020	13F
ROYCE & ASSOCIATES LP	13F	Company	1.3%	598,756	$71,102,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	577,553	$68,584,000	—	31 Dec 2020	13F
HealthCor Management, L.P.	13F	Company	1.2%	566,370	$67,256,000	—	31 Dec 2020	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	1.1%	532,642	$63,251,000	—	31 Dec 2020	13F
NORGES BANK	13F	Company	1.1%	503,369	$59,775,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	1.1%	496,431	$58,951,000	—	31 Dec 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1%	484,103	$57,488,000	—	31 Dec 2020	13F
ANCHOR CAPITAL ADVISORS LLC	13F	Company	0.96%	446,735	$53,050,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.87%	406,692	$48,294,000	—	31 Dec 2020	13F
Nitorum Capital, L.P.	13F	Company	0.87%	402,100	$47,749,000	—	31 Dec 2020	13F
AEGON ASSET MANAGEMENT UK PLC	13F	Company	0.85%	396,823	$47,123,000	—	31 Dec 2020	13F
Holocene Advisors, LP	13F	Company	0.71%	328,266	$38,982,000	—	31 Dec 2020	13F
Gestion Carmignac	13F	Individual	0.66%	305,547	$36,284,000	—	31 Dec 2020	13F
GW&K Investment Management, LLC	13F	Company	0.64%	296,351	$35,191,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.63%	291,751	$34,646,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.62%	290,425	$34,488,000	—	31 Dec 2020	13F
Polar Capital Holdings Plc	13F	Company	0.62%	289,090	$34,329,000	—	31 Dec 2020	13F
THORNBURG INVESTMENT MANAGEMENT INC	13F	Company	0.61%	284,147	$33,742,000	—	31 Dec 2020	13F
Point72 Asset Management, L.P.	13F	Company	0.6%	280,432	$33,301,000	—	31 Dec 2020	13F
ROYAL BANK OF CANADA	13F	Company	0.59%	275,810	$32,754,000	—	31 Dec 2020	13F
Iron Triangle Partners LP	13F	Company	0.59%	275,453	$32,710,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.58%	269,755	$32,033,000	—	31 Dec 2020	13F
Boston Trust Walden Corp	13F	Company	0.55%	255,172	$30,301,000	—	31 Dec 2020	13F
Aristotle Capital Boston, LLC	13F	Company	0.5%	231,470	$27,487,000	—	31 Dec 2020	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.5%	231,354	$27,473,000	—	31 Dec 2020	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.5%	230,385	$27,358,000	—	31 Dec 2020	13F
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO	13F	Company	0.48%	224,477	$26,657,000	—	31 Dec 2020	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.44%	206,094	$24,474,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.44%	204,796	$24,320,000	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	0.43%	201,752	$23,957,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	0.4%	183,625	$21,806,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.37%	169,949	$20,181,000	—	31 Dec 2020	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.35%	164,944	$19,587,000	—	31 Dec 2020	13F

Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q1 2021

As of 31 Mar 2021, HAEMONETICS CORP - Common Stock (HAE) was held by 288 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,961,531 shares. The largest 10 holders included Capital Research Global Investors, VANGUARD GROUP INC, BlackRock Inc., Neuberger Berman Group LLC, FMR LLC, FRANKLIN RESOURCES INC, WELLINGTON MANAGEMENT GROUP LLP, Capital World Investors, RENAISSANCE TECHNOLOGIES LLC, and STATE STREET CORP. This page lists 288 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

278

Q1 2021 holders

288

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.